CARLOS ALVAREZ: Open Payments
NPI 1891805610 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,277 in 156 payments from 38 companies in 2025. Trend: 2023 $3,946 · 2024 $3,987 · 2025 $10,277
Debt forgiveness: $6,278Food & beverage: $3,957Education: $43
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 4 | $6,319 |
| ABBVIE INC. | 21 | $425 |
| Merck Sharp & Dohme LLC | 12 | $266 |
| Corcept Therapeutics | 6 | $235 |
| Novo Nordisk Inc | 6 | $229 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $228 |
| Amgen Inc. | 11 | $225 |
| Lilly USA, LLC | 8 | $223 |
| ViiV Healthcare Company | 4 | $202 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $191 |
Products named: GRAFIX PL, Korlym, Kerendia, VERQUVO, APRETUDE, JOURNAVX, Veozah, JARDIANCE.
Industry payments across CA — which companies pay providers there.
